Paydirt
KG
Insider

Katherine Goodrich

Director

Katherine Goodrich (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $183K of TARS (2,954 sh × $62.08, as filed), executed Jun 15.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$183K
shares × price, as filed
Last traded
Jun 15
Filed Jun 17

Median ADV $68.4M across their filed names

Open performance→
Volume by month
$183K$92K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2026 · sells $183K
Buys $0 Sells $183K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TARS Tarsus Pharmaceuticals, Inc. TARS · 0 buys · 1 sell 1 filing
Recent filings
TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $183K
2,954 sh × $62.08
Exec Jun 15
Filed Jun 17 · 5:30 PM ET